▶ 調査レポート

世界のアルツハイマー病に関連する認知症市場：市場規模・現状・予測
• 英文タイトル：Global Dementia Associated with Alzimer’s Disease Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界のアルツハイマー病に関連する認知症市場：市場規模・現状・予測 / Global Dementia Associated with Alzimer’s Disease Market Size, Status and Forecast 2019-2025 / QYR9N7075資料のイメージです。• レポートコード：QYR9N7075
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、アルツハイマー病に関連する認知症のグローバル市場について調査・分析したレポートで、種類別（コリン作動性/コリンエステラーゼ（ChE）阻害剤、メマンチン、配合薬（メマンチン＆ドネペジル）、その他）、用途別（病院薬局、小売、オンライン販売）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・アルツハイマー病に関連する認知症の世界市場規模
・主要企業別市場シェア
・アルツハイマー病に関連する認知症の世界市場規模：種類別（コリン作動性/コリンエステラーゼ（ChE）阻害剤、メマンチン、配合薬（メマンチン＆ドネペジル）、その他）
・アルツハイマー病に関連する認知症の世界市場規模：用途別（病院薬局、小売、オンライン販売）
・アルツハイマー病に関連する認知症のアメリカ市場規模（種類別、用途別）
・アルツハイマー病に関連する認知症のヨーロッパ市場規模（種類別、用途別）
・アルツハイマー病に関連する認知症の中国市場規模（種類別、用途別）
・アルツハイマー病に関連する認知症の日本市場規模（種類別、用途別）
・アルツハイマー病に関連する認知症の東南アジア市場規模（種類別、用途別）
・アルツハイマー病に関連する認知症のインド市場規模（種類別、用途別）
・アルツハイマー病に関連する認知症の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・アルツハイマー病に関連する認知症の世界市場予測（2019年-2025年）
・アルツハイマー病に関連する認知症の地域別市場予測（2019年-2025年）
...

The global dementia associated with Alzheimer’s disease market has been segmented based on drug class and distribution channel. In terms of drug class, the global market has been classified into cholinergic/ cholinesterase (ChE) inhibitor, memantine, and combined drug (memantine & donepezil) and others. The cholinergic/ cholinesterase (ChE) inhibitor segment dominates the dementia associated with Alzheimer’s disease market,In 2018, the global Dementia Associated with Alzimer’s Disease market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Dementia Associated with Alzimer’s Disease status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Dementia Associated with Alzimer’s Disease development in United States, Europe and China.

The key players covered in this study
Merz Pharma
Novartis
Allergan
Pfizer
Daiichi Sankyo Company
Ono Pharmaceutical
Johnson & Johnson
Eisai
H. Lundbeck
F. Hoffmann-La Roche

Market segment by Type, the product can be split into
Cholinergic/ Cholinesterase (ChE) Inhibitors
Memantine
Combined Drug (Memantine & Donepezil)
Others

Market segment by Application, split into
Hospital Pharmacies
Retail
Online Sales

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Dementia Associated with Alzimer’s Disease status, future forecast, growth opportunity, key market and key players.
To present the Dementia Associated with Alzimer’s Disease development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Dementia Associated with Alzimer’s Disease are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Dementia Associated with Alzimer’s Disease Market Size Growth Rate by Type (2014-2025)
1.4.2 Cholinergic/ Cholinesterase (ChE) Inhibitors
1.4.3 Memantine
1.4.4 Combined Drug (Memantine & Donepezil)
1.4.5 Others
1.5 Market by Application
1.5.1 Global Dementia Associated with Alzimer’s Disease Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail
1.5.4 Online Sales
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Dementia Associated with Alzimer’s Disease Market Size
2.2 Dementia Associated with Alzimer’s Disease Growth Trends by Regions
2.2.1 Dementia Associated with Alzimer’s Disease Market Size by Regions (2014-2025)
2.2.2 Dementia Associated with Alzimer’s Disease Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Dementia Associated with Alzimer’s Disease Market Size by Manufacturers
3.1.1 Global Dementia Associated with Alzimer’s Disease Revenue by Manufacturers (2014-2019)
3.1.2 Global Dementia Associated with Alzimer’s Disease Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Dementia Associated with Alzimer’s Disease Market Concentration Ratio (CR5 and HHI)
3.2 Dementia Associated with Alzimer’s Disease Key Players Head office and Area Served
3.3 Key Players Dementia Associated with Alzimer’s Disease Product/Solution/Service
3.4 Date of Enter into Dementia Associated with Alzimer’s Disease Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Dementia Associated with Alzimer’s Disease Market Size by Type (2014-2019)
4.2 Global Dementia Associated with Alzimer’s Disease Market Size by Application (2014-2019)

5 United States
5.1 United States Dementia Associated with Alzimer’s Disease Market Size (2014-2019)
5.2 Dementia Associated with Alzimer’s Disease Key Players in United States
5.3 United States Dementia Associated with Alzimer’s Disease Market Size by Type
5.4 United States Dementia Associated with Alzimer’s Disease Market Size by Application

6 Europe
6.1 Europe Dementia Associated with Alzimer’s Disease Market Size (2014-2019)
6.2 Dementia Associated with Alzimer’s Disease Key Players in Europe
6.3 Europe Dementia Associated with Alzimer’s Disease Market Size by Type
6.4 Europe Dementia Associated with Alzimer’s Disease Market Size by Application

7 China
7.1 China Dementia Associated with Alzimer’s Disease Market Size (2014-2019)
7.2 Dementia Associated with Alzimer’s Disease Key Players in China
7.3 China Dementia Associated with Alzimer’s Disease Market Size by Type
7.4 China Dementia Associated with Alzimer’s Disease Market Size by Application

8 Japan
8.1 Japan Dementia Associated with Alzimer’s Disease Market Size (2014-2019)
8.2 Dementia Associated with Alzimer’s Disease Key Players in Japan
8.3 Japan Dementia Associated with Alzimer’s Disease Market Size by Type
8.4 Japan Dementia Associated with Alzimer’s Disease Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Dementia Associated with Alzimer’s Disease Market Size (2014-2019)
9.2 Dementia Associated with Alzimer’s Disease Key Players in Southeast Asia
9.3 Southeast Asia Dementia Associated with Alzimer’s Disease Market Size by Type
9.4 Southeast Asia Dementia Associated with Alzimer’s Disease Market Size by Application

10 India
10.1 India Dementia Associated with Alzimer’s Disease Market Size (2014-2019)
10.2 Dementia Associated with Alzimer’s Disease Key Players in India
10.3 India Dementia Associated with Alzimer’s Disease Market Size by Type
10.4 India Dementia Associated with Alzimer’s Disease Market Size by Application

11 Central & South America
11.1 Central & South America Dementia Associated with Alzimer’s Disease Market Size (2014-2019)
11.2 Dementia Associated with Alzimer’s Disease Key Players in Central & South America
11.3 Central & South America Dementia Associated with Alzimer’s Disease Market Size by Type
11.4 Central & South America Dementia Associated with Alzimer’s Disease Market Size by Application

12 International Players Profiles
12.1 Merz Pharma
12.1.1 Merz Pharma Company Details
12.1.2 Company Description and Business Overview
12.1.3 Dementia Associated with Alzimer’s Disease Introduction
12.1.4 Merz Pharma Revenue in Dementia Associated with Alzimer’s Disease Business (2014-2019)
12.1.5 Merz Pharma Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Dementia Associated with Alzimer’s Disease Introduction
12.2.4 Novartis Revenue in Dementia Associated with Alzimer’s Disease Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Allergan
12.3.1 Allergan Company Details
12.3.2 Company Description and Business Overview
12.3.3 Dementia Associated with Alzimer’s Disease Introduction
12.3.4 Allergan Revenue in Dementia Associated with Alzimer’s Disease Business (2014-2019)
12.3.5 Allergan Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Dementia Associated with Alzimer’s Disease Introduction
12.4.4 Pfizer Revenue in Dementia Associated with Alzimer’s Disease Business (2014-2019)
12.4.5 Pfizer Recent Development
12.5 Daiichi Sankyo Company
12.5.1 Daiichi Sankyo Company Company Details
12.5.2 Company Description and Business Overview
12.5.3 Dementia Associated with Alzimer’s Disease Introduction
12.5.4 Daiichi Sankyo Company Revenue in Dementia Associated with Alzimer’s Disease Business (2014-2019)
12.5.5 Daiichi Sankyo Company Recent Development
12.6 Ono Pharmaceutical
12.6.1 Ono Pharmaceutical Company Details
12.6.2 Company Description and Business Overview
12.6.3 Dementia Associated with Alzimer’s Disease Introduction
12.6.4 Ono Pharmaceutical Revenue in Dementia Associated with Alzimer’s Disease Business (2014-2019)
12.6.5 Ono Pharmaceutical Recent Development
12.7 Johnson & Johnson
12.7.1 Johnson & Johnson Company Details
12.7.2 Company Description and Business Overview
12.7.3 Dementia Associated with Alzimer’s Disease Introduction
12.7.4 Johnson & Johnson Revenue in Dementia Associated with Alzimer’s Disease Business (2014-2019)
12.7.5 Johnson & Johnson Recent Development
12.8 Eisai
12.8.1 Eisai Company Details
12.8.2 Company Description and Business Overview
12.8.3 Dementia Associated with Alzimer’s Disease Introduction
12.8.4 Eisai Revenue in Dementia Associated with Alzimer’s Disease Business (2014-2019)
12.8.5 Eisai Recent Development
12.9 H. Lundbeck
12.9.1 H. Lundbeck Company Details
12.9.2 Company Description and Business Overview
12.9.3 Dementia Associated with Alzimer’s Disease Introduction
12.9.4 H. Lundbeck Revenue in Dementia Associated with Alzimer’s Disease Business (2014-2019)
12.9.5 H. Lundbeck Recent Development
12.10 F. Hoffmann-La Roche
12.10.1 F. Hoffmann-La Roche Company Details
12.10.2 Company Description and Business Overview
12.10.3 Dementia Associated with Alzimer’s Disease Introduction
12.10.4 F. Hoffmann-La Roche Revenue in Dementia Associated with Alzimer’s Disease Business (2014-2019)
12.10.5 F. Hoffmann-La Roche Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Dementia Associated with Alzimer’s Disease Key Market Segments
Table Key Players Dementia Associated with Alzimer’s Disease Covered
Table Global Dementia Associated with Alzimer’s Disease Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Dementia Associated with Alzimer’s Disease Market Size Market Share by Type 2014-2025
Figure Cholinergic/ Cholinesterase (ChE) Inhibitors Figures
Table Key Players of Cholinergic/ Cholinesterase (ChE) Inhibitors
Figure Memantine Figures
Table Key Players of Memantine
Figure Combined Drug (Memantine & Donepezil) Figures
Table Key Players of Combined Drug (Memantine & Donepezil)
Figure Others Figures
Table Key Players of Others
Table Global Dementia Associated with Alzimer’s Disease Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Retail Case Studies
Figure Online Sales Case Studies
Figure Dementia Associated with Alzimer’s Disease Report Years Considered
Table Global Dementia Associated with Alzimer’s Disease Market Size 2014-2025 (Million US$)
Figure Global Dementia Associated with Alzimer’s Disease Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Dementia Associated with Alzimer’s Disease Market Size by Regions 2014-2025 (Million US$)
Table Global Dementia Associated with Alzimer’s Disease Market Size by Regions 2014-2019 (Million US$)
Table Global Dementia Associated with Alzimer’s Disease Market Share by Regions 2014-2019
Figure Global Dementia Associated with Alzimer’s Disease Market Share by Regions 2014-2019
Figure Global Dementia Associated with Alzimer’s Disease Market Share by Regions 2019
Table Market Top Trends
Table Global Dementia Associated with Alzimer’s Disease Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Dementia Associated with Alzimer’s Disease Market Share by Manufacturers (2014-2019)
Figure Global Dementia Associated with Alzimer’s Disease Market Share by Manufacturers in 2018
Table Global Dementia Associated with Alzimer’s Disease Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Dementia Associated with Alzimer’s Disease Product/Solution/Service
Table Date of Enter into Dementia Associated with Alzimer’s Disease Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Dementia Associated with Alzimer’s Disease Market Size by Type (2014-2019) (Million US$)
Table Global Dementia Associated with Alzimer’s Disease Market Size Share by Type (2014-2019)
Figure Global Dementia Associated with Alzimer’s Disease Market Size Market Share by Type (2014-2019)
Table Global Dementia Associated with Alzimer’s Disease Market Size by Application (2014-2019) (Million US$)
Table Global Dementia Associated with Alzimer’s Disease Market Size Share by Application (2014-2019)
Figure Global Dementia Associated with Alzimer’s Disease Market Size Market Share by Application (2014-2019)
Figure Global Dementia Associated with Alzimer’s Disease Revenue Market Share by Application in 2018
Figure United States Dementia Associated with Alzimer’s Disease Market Size 2014-2019 (Million US$)
Table United States Key Players Dementia Associated with Alzimer’s Disease Revenue (2018-2019) (Million US$)
Table United States Key Players Dementia Associated with Alzimer’s Disease Market Share (2018-2019)
Table United States Dementia Associated with Alzimer’s Disease Market Size by Type (2014-2019) (Million US$)
Table United States Dementia Associated with Alzimer’s Disease Market Share by Type (2014-2019)
Table United States Dementia Associated with Alzimer’s Disease Market Size by Application (2014-2019) (Million US$)
Table United States Dementia Associated with Alzimer’s Disease Market Share by Application (2014-2019)
Figure Europe Dementia Associated with Alzimer’s Disease Market Size 2014-2019 (Million US$)
Table Europe Key Players Dementia Associated with Alzimer’s Disease Revenue (2018-2019) (Million US$)
Table Europe Key Players Dementia Associated with Alzimer’s Disease Market Share (2018-2019)
Table Europe Dementia Associated with Alzimer’s Disease Market Size by Type (2014-2019) (Million US$)
Table Europe Dementia Associated with Alzimer’s Disease Market Share by Type (2014-2019)
Table Europe Dementia Associated with Alzimer’s Disease Market Size by Application (2014-2019) (Million US$)
Table Europe Dementia Associated with Alzimer’s Disease Market Share by Application (2014-2019)
Figure China Dementia Associated with Alzimer’s Disease Market Size 2014-2019 (Million US$)
Table China Key Players Dementia Associated with Alzimer’s Disease Revenue (2018-2019) (Million US$)
Table China Key Players Dementia Associated with Alzimer’s Disease Market Share (2018-2019)
Table China Dementia Associated with Alzimer’s Disease Market Size by Type (2014-20189) (Million US$)
Table China Dementia Associated with Alzimer’s Disease Market Share by Type (2014-2019)
Table China Dementia Associated with Alzimer’s Disease Market Size by Application (2014-2019) (Million US$)
Table China Dementia Associated with Alzimer’s Disease Market Share by Application (2014-2019)
Figure Japan Dementia Associated with Alzimer’s Disease Market Size 2014-2019 (Million US$)
Table Japan Key Players Dementia Associated with Alzimer’s Disease Revenue (2018-2019) (Million US$)
Table Japan Key Players Dementia Associated with Alzimer’s Disease Market Share (2018-2019)
Table Japan Dementia Associated with Alzimer’s Disease Market Size by Type (2014-2019) (Million US$)
Table Japan Dementia Associated with Alzimer’s Disease Market Share by Type (2014-2019)
Table Japan Dementia Associated with Alzimer’s Disease Market Size by Application (2014-2019) (Million US$)
Table Japan Dementia Associated with Alzimer’s Disease Market Share by Application (2014-2019)
Figure Southeast Asia Dementia Associated with Alzimer’s Disease Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Dementia Associated with Alzimer’s Disease Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Dementia Associated with Alzimer’s Disease Market Share (2018-2019)
Table Southeast Asia Dementia Associated with Alzimer’s Disease Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Dementia Associated with Alzimer’s Disease Market Share by Type (2014-2019)
Table Southeast Asia Dementia Associated with Alzimer’s Disease Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Dementia Associated with Alzimer’s Disease Market Share by Application (2014-2019)
Figure India Dementia Associated with Alzimer’s Disease Market Size 2014-2019 (Million US$)
Table India Key Players Dementia Associated with Alzimer’s Disease Revenue (2018-2019) (Million US$)
Table India Key Players Dementia Associated with Alzimer’s Disease Market Share (2018-2019)
Table India Dementia Associated with Alzimer’s Disease Market Size by Type (2014-2019) (Million US$)
Table India Dementia Associated with Alzimer’s Disease Market Share by Type (2014-2019)
Table India Dementia Associated with Alzimer’s Disease Market Size by Application (2014-2019) (Million US$)
Table India Dementia Associated with Alzimer’s Disease Market Share by Application (2014-2019)
Figure Central & South America Dementia Associated with Alzimer’s Disease Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Dementia Associated with Alzimer’s Disease Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Dementia Associated with Alzimer’s Disease Market Share (2018-2019)
Table Central & South America Dementia Associated with Alzimer’s Disease Market Size by Type (2014-2019) (Million US$)
Table Central & South America Dementia Associated with Alzimer’s Disease Market Share by Type (2014-2019)
Table Central & South America Dementia Associated with Alzimer’s Disease Market Size by Application (2014-2019) (Million US$)
Table Central & South America Dementia Associated with Alzimer’s Disease Market Share by Application (2014-2019)
Table Merz Pharma Company Details
Table Merz Pharma Revenue in Dementia Associated with Alzimer’s Disease Business (2014-2019) (Million US$)
Figure Merz Pharma Revenue Growth Rate in Dementia Associated with Alzimer’s Disease Business (2014-2019)
Table Merz Pharma Recent Development
Table Novartis Company Details
Table Novartis Revenue in Dementia Associated with Alzimer’s Disease Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Dementia Associated with Alzimer’s Disease Business (2014-2019)
Table Novartis Recent Development
Table Allergan Company Details
Table Allergan Revenue in Dementia Associated with Alzimer’s Disease Business (2014-2019)(Million US$)
Figure Allergan Revenue Growth Rate in Dementia Associated with Alzimer’s Disease Business (2014-2019)
Table Allergan Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Dementia Associated with Alzimer’s Disease Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Dementia Associated with Alzimer’s Disease Business (2014-2019)
Table Pfizer Recent Development
Table Daiichi Sankyo Company Company Details
Table Daiichi Sankyo Company Revenue in Dementia Associated with Alzimer’s Disease Business (2014-2019)(Million US$)
Figure Daiichi Sankyo Company Revenue Growth Rate in Dementia Associated with Alzimer’s Disease Business (2014-2019)
Table Daiichi Sankyo Company Recent Development
Table Ono Pharmaceutical Company Details
Table Ono Pharmaceutical Revenue in Dementia Associated with Alzimer’s Disease Business (2014-2019)(Million US$)
Figure Ono Pharmaceutical Revenue Growth Rate in Dementia Associated with Alzimer’s Disease Business (2014-2019)
Table Ono Pharmaceutical Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Dementia Associated with Alzimer’s Disease Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Dementia Associated with Alzimer’s Disease Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Eisai Company Details
Table Eisai Revenue in Dementia Associated with Alzimer’s Disease Business (2014-2019)(Million US$)
Figure Eisai Revenue Growth Rate in Dementia Associated with Alzimer’s Disease Business (2014-2019)
Table Eisai Recent Development
Table H. Lundbeck Company Details
Table H. Lundbeck Revenue in Dementia Associated with Alzimer’s Disease Business (2014-2019)(Million US$)
Figure H. Lundbeck Revenue Growth Rate in Dementia Associated with Alzimer’s Disease Business (2014-2019)
Table H. Lundbeck Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Dementia Associated with Alzimer’s Disease Business (2014-2019)(Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Dementia Associated with Alzimer’s Disease Business (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table Global Dementia Associated with Alzimer’s Disease Market Size by Regions (Million US$) 2019-2025
Figure Global Dementia Associated with Alzimer’s Disease Market Size Share by Regions (2019-2025)
Figure Global Dementia Associated with Alzimer’s Disease Market Size Share by Regions in 2025
Figure United States Dementia Associated with Alzimer’s Disease Market Size Forecast (2019-2025)(Million USD)
Figure Europe Dementia Associated with Alzimer’s Disease Market Size Forecast (2019-2025)(Million USD)
Figure China Dementia Associated with Alzimer’s Disease Market Size Forecast (2019-2025)(Million USD)
Figure Japan Dementia Associated with Alzimer’s Disease Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Dementia Associated with Alzimer’s Disease Market Size Forecast (2019-2025)(Million USD)
Figure India Dementia Associated with Alzimer’s Disease Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Dementia Associated with Alzimer’s Disease Market Size Forecast (2019-2025)(Million USD)
Table Global Dementia Associated with Alzimer’s Disease Market Size by Product (2019-2025) (Million US$)
Figure Global Dementia Associated with Alzimer’s Disease Market Size by Product (2019-2025)
Figure Global Dementia Associated with Alzimer’s Disease Market Size by Product in 2025
Table Global Dementia Associated with Alzimer’s Disease Market Size by Application (2019-2025) (Million US$)
Figure Global Dementia Associated with Alzimer’s Disease Market Size by Application (2019-2025)
Figure Global Dementia Associated with Alzimer’s Disease Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の多発性梗塞性認知症市場：市場規模・現状・予測
    Global Multi-Infarct Dementia Market Size, Status and Forecast 2019-2025
    QYR9N7599 2019年6月14日 99Pages
    当資料は、多発性梗塞性認知症のグローバル市場について調査・分析したレポートで、種類別（薬理学的治療、非薬理学的治療）、用途別（学術、病院、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

  • 世界のレビー小体型認知症薬市場：市場規模・現状・予測
    Global Lewy Body Dementia Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7450 2019年6月14日 104Pages
    当資料は、レビー小体型認知症薬のグローバル市場について調査・分析したレポートで、種類別（モダフィニル、ベンゾジアゼピン、抗うつ薬、コリンエステラーゼ阻害剤、抗精神病薬、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の...
  • 世界のフォンヴィレブランド病治療市場：市場規模・現状・予測
    Global Von Willebrand Disease Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8188 2019年6月14日 93Pages
    当資料は、フォンヴィレブランド病治療のグローバル市場について調査・分析したレポートで、種類別（ヴェイヴォンディ、フミン酸-P、英数字、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれてい...
  • 世界のクッシング病治療市場：市場規模・現状・予測
    Global Cushing’s Disease Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7048 2019年6月14日 94Pages
    当資料は、クッシング病治療のグローバル市場について調査・分析したレポートで、種類別（ケトコナゾール、ミトタン、アミノグルテチミド、メチラポン、ミフェプリストン、その他）、用途別（病院薬局、小売薬局、ドラッグストア、診療所、Eコマース/オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東...
  • 世界のサイトメガロウイルス病治療市場：市場規模・現状・予測
    Global Cytomegalovirus Disease Treatments Market Size, Status and Forecast 2019-2025
    QYR9N7058 2019年6月14日 96Pages
    当資料は、サイトメガロウイルス病治療のグローバル市場について調査・分析したレポートで、種類別（ガンシクロビル、バルガンシクロビル、フォスカーネット、シドフォビル、その他）、用途別（幹細胞移植、臓器移植、先天性CMV感染、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南...
  • 世界のクローン病市場：市場規模・現状・予測
    Global Crohn's Disease Market Size, Status and Forecast 2019-2025
    QYR9N7042 2019年6月14日 99Pages
    当資料は、クローン病のグローバル市場について調査・分析したレポートで、種類別（手術、薬物療法）、用途別（病院、外来手術センター、その他、）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・...
  • 世界の胃食道逆流症（GERD）治療薬市場：市場規模・現状・予測
    Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N7228 2019年6月14日 96Pages
    当資料は、胃食道逆流症（GERD）治療薬のグローバル市場について調査・分析したレポートで、種類別（制酸剤、運動促進剤、H2受容体ブロッカー、プロトンポンプ阻害剤（PPI））、用途別（胸焼け、酸逆流障害）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、...
  • 世界の人獣共通感染症の治療市場：市場規模・現状・予測
    Global Zoonotic Disease Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8217 2019年6月14日 94Pages
    当資料は、人獣共通感染症の治療のグローバル市場について調査・分析したレポートで、種類別（ウイルス性肝炎、狂犬病、回帰熱、結核、マラリア）、用途別（病院、診療所）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界のRefsum病治療市場：市場規模・現状・予測
    Global Refsum Disease Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7944 2019年6月14日 90Pages
    当資料は、Refsum病治療のグローバル市場について調査・分析したレポートで、種類別（手術療法、薬）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・Ref...
  • 世界の獣医感染症治療薬市場：市場規模・現状・予測
    Global Veterinary Infectious Disease Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N8175 2019年6月14日 98Pages
    当資料は、獣医感染症治療薬のグローバル市場について調査・分析したレポートで、種類別（抗生物質、抗ウイルス薬、抗真菌、殺虫剤、駆虫薬）、用途別（獣医病院、獣医クリニック、獣医薬局、研究機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報な...
  • 世界のレビー小体型認知症薬市場：市場規模・現状・予測世界のレビー小体型認知症薬市場：市場規模・現状・予測 Lewy body dementia (LBD, sometimes referred to as Lewy body disorder) is an umbrella term that includes Parkinson's disease dementia (PDD) and dementia with Lewy bodies (DLB), two dementias characterized by abnormal deposits of the protein alpha-synuclein in the brain.In 2018, the global Lewy Body D…
  • 世界の多発性梗塞性認知症市場：市場規模・現状・予測世界の多発性梗塞性認知症市場：市場規模・現状・予測 Multi-cerebral infarction dementia is a series of small strokes that cause disruption of blood flow to the brain. It is the highest incidence among people over 65 years of age.The increase in the global elderly population has also contributed to the development of the global market for multi-infarct…
  • 世界のクッシング病治療市場：市場規模・現状・予測世界のクッシング病治療市場：市場規模・現状・予測 Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…
  • 世界のパーキンソン病薬市場：市場規模・現状・予測世界のパーキンソン病薬市場：市場規模・現状・予測 In 2018, the global Parkinson Disease Drug market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Parkinson Disease Drug status, future forecast, growth opportunity, key market and key playe…
  • 世界のまれな神経疾患治療市場：市場規模・現状・予測世界のまれな神経疾患治療市場：市場規模・現状・予測 In 2018, the global Rare Neurological Disease Treatment market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Rare Neurological Disease Treatment status, future forecast, growth opportunity, key mark…